Citations

Citations to this article as recorded by  

• Impact of Maternal Obesity on Neonatal TSH Levels: A Prospective Study on the Influence of BMI
  Gökçe Çıplak, Gülsüm Kadıoğlu Şimşek, Özhan Akyol, Aylin Kayalı Akyol, Hayriye Gözde Kanmaz Kutman, Fuat Emre Canpolat
  American Journal of Perinatology.2026; 43(07): 907.     CrossRef
• Examining the Impact of Preconception Physical Activity on Offspring Outcomes Linked to Obesity
  Nicholas O’Rourke, Luba Marderfeld, Arthur Dantas, Abbey E. Corson, Meaghan MacDonald, Zachary M. Ferraro, Taniya S. Nagpal, Kristi B. Adamo
  Current Obesity Reports.2026;[Epub]     CrossRef
• Integrating multi-omics and digital phenotyping for precision care in gestational diabetes
  Viktoria Xega, Jun-Li Liu
  Metabolism and Diseases.2026; 1(1): 100002.     CrossRef
• Advanced image processing and pattern-matching algorithms assisted enzyme/hydrogel platform for dual-signal detection of glucose
  Yeping Wang, Zhanwei Liang, Haixia Xu, Ye Wang, Weiwei Qu, Yanjun Hu, Kaixin Chen, Tao Peng, Xiaoqing Li, Lidong Wu
  Talanta.2026; 303: 129484.     CrossRef
• Maternal pregnancy complications and offspring autism spectrum disorder risk: an umbrella review
  Manman Zhu, Hao Yang, Bo Feng, Yi Jiang, Yaoyao Zhang
  Psychiatry Research.2026; 358: 116987.     CrossRef
• A unified machine learning framework for gestational diabetes mellitus diagnosis
  Ahmad Hassan, Saima Gulzar Ahmad, Ehsan Ullah Munir, Hassan Rabah, Slavisa Jovanovic, Naeem Ramzan
  Discover Applied Sciences.2026;[Epub]     CrossRef
• Tight versus less tight glycaemic targets for women with gestational diabetes mellitus: a randomised controlled trial
  Polina V. Popova, Elena A. Vasukova, Alexandra S. Tkachuk, Anna D. Anopova, Irina S. Nemikina, Elena V. Verbitskaya, Angelina I. Eriskovskaya, Elena Y. Vasilieva, Irina E. Zazerskaya, Ofeliia A. Bettikher, Olga A. Li, Tatiana M. Pervunina, Viswanathan Moh
  Diabetes Research and Clinical Practice.2026; 234: 113151.     CrossRef
• Inflammatory mediators linking periodontal disease and gestational diabetes mellitus: biological plausibility and clinical implications
  Mai Ahmed, Dada Oluwaseyi Temilola, Mushi Matjila, Manogari Chetty
  Periodontal and Implant Research.2026;[Epub]     CrossRef
• Postpartum Glucose Intolerance in Women with a History of Gestational Diabetes Mellitus: An In-Depth Review
  Kyung-Soo Kim, Soo-Kyung Kim, Yong-Wook Cho
  Endocrinology and Metabolism.2026; 41(1): 26.     CrossRef
• Dose-response relationship between early pregnancy blood pressure and gestational diabetes mellitus based on propensity score matching: a retrospective study
  Rongrong Han, Yanqiang Guo, Minqiang Zhang, Jinhua Pan
  BMC Pregnancy and Childbirth.2026;[Epub]     CrossRef
• The impact of gestational diabetes mellitus on fetal neural development: A systematic review
  Zenia Safwan, Emaan Ijaz, Hafsa Shamim, Arooj Fatima, Ashfaq Ahmad, Ahmed Murtaz Khalid
  Brain and Development.2026; 48(2): 104521.     CrossRef
• Long-term risk of offspring type 1 and type 2 diabetes following maternal gestational diabetes mellitus: a nationwide birth cohort study with 10-year follow-up
  Joon Ho Moon, Han Na Jung, Bongseong Kim, Jaehyun Kim, Young Mi Jung, Hyeon Ji Kim, Jee Yoon Park, Tae Jung Oh, Soo Heon Kwak, Kyung-Do Han, Sung Hee Choi
  BMC Medicine.2026;[Epub]     CrossRef
• Umbilical cord asprosin and subfatin levels in relation to neonatal metabolic outcomes in gestational diabetes mellitus: a cross-sectional study
  Figen Efe Camili, Ozlem Kemer Aycan, Merve Akis Yilmaz, Bayram Burak Ceviz, Selim Afsar, Gurhan Guney, Mine Islimye Taskin
  BMC Endocrine Disorders.2026;[Epub]     CrossRef
• Small Extracellular Vesicles in Gestational Diabetes Mellitus: Current Landscape and Emerging Diagnostic Horizons
  Mai Ahmed, Dada Oluwaseyi Temilola, Mushi Matjila, Manogari Chetty
  Journal of Extracellular Biology.2026;[Epub]     CrossRef
• The Economic Burden of Gestational Diabetes and Body Mass Index Changes Between Pregnancies: A Retrospective Cohort Study
  Rashidul Alam Mahumud, Glynis Pauline Ross, Adam Mackie, Rachael L. Morton, Kirsten I. Black
  BJOG: An International Journal of Obstetrics & Gynaecology.2026;[Epub]     CrossRef
• Emerging ultrasound-based imaging of the placenta during complications of pregnancy
  Lili Shi, Claudia I. García Zorba, Miller A. Dickerson, Carolyn L. Bayer
  Placenta.2026;[Epub]     CrossRef
• Diabetes in Pregnancy in Korea: Prevalence, Clinical Characteristics, and Postpartum Comorbidities
  Joon Ho Moon, Han Na Jung, Bongseong Kim, Seung-Hyun Ko, Soo Heon Kwak, Kyung-Do Han, Sung Hee Choi
  Diabetes & Metabolism Journal.2026; 50(2): 280.     CrossRef
• The correlation between triglyceride-glucose index in early pregnancy (<20 weeks) and pregnancy complications and adverse pregnancy outcomes: a systematic review and meta-analysis
  Wenli Zhang, Junzhi Wang, Liangliang Chu, Xinyu Pi, Guochun Zhang
  Frontiers in Medicine.2026;[Epub]     CrossRef
• Mixed Heavy Metal Exposure During Pregnancy Induces GDM-like Metabolic Dysfunction Associated with Glycer-Ophospholipid Metabolic Reprogramming and Altered Insig1 Expression: A Multi-Omics Study in Rats
  Tianao Sun, Zhanyue Zheng, Yongjie Ma, Minglian Pan, Yingjie Zhou, Jingxia Wei, Xinyu Yuan, Jinhao Wan, You Li, Yan Sun
  Toxics.2026; 14(4): 351.     CrossRef
• Neutrophils and neutrophil extracellular traps in diabetes mellitus and its complications: Mechanisms and therapeutic implications
  Li Lei, Jiaying Liu, Yunrong Li, Bo Huang, Zhenzhuang Zou
  iScience.2026; 29(5): 115585.     CrossRef
• Antenatal Screening Compliance for Gestational Diabetes and Its Effect on Maternal-Fetal Outcomes: A Pre- and Post-Intervention Clinical Audit
  Shumaila Jabeen, Hina Mumtaz, Maryam Hafeez
  Biological and Clinical Sciences Research Journal.2026; 7(3): 34.     CrossRef
• Mogrosides as Dual-Function Sweeteners: A Comprehensive Review of Extraction, Metabolism, Antidiabetic Mechanisms, and Food Applications
  Qiqi Feng, Tao Wang, Qing Wang, Hongyu Pan, Yujie Zhong, Yongliang Zhuang
  Nutrients.2026; 18(9): 1342.     CrossRef
• Association and discriminative value of early-pregnancy neck circumference for gestational diabetes mellitus: A prospective study based on logistic regression and machine learning models
  Feng Wang, Xiaohua Li, Huanliu He, Weidi Guo, Jiali Huang, Dan Li
  International Journal of Diabetes in Developing Countries.2026;[Epub]     CrossRef
• Transient fetal hyperglycemia reprograms adipogenesis, lipogenesis, and insulin signaling in zebrafish
  Bridget Konadu, Madelyn K. Logan, Carol K. Cox, Kristin S. Edwards, Joshua S. Speed, Yann Gibert
  Biomedicine & Pharmacotherapy.2026; 199: 119445.     CrossRef
• Unveiling Gestational Diabetes: An Overview of Pathophysiology and Management
  Rahul Mittal, Karan Prasad, Joana R. N. Lemos, Giuliana Arevalo, Khemraj Hirani
  International Journal of Molecular Sciences.2025; 26(5): 2320.     CrossRef
• Advancing Early Prediction of Gestational Diabetes Mellitus with Circular RNA Biomarkers
  Joon Ho Moon, Sung Hee Choi
  Diabetes & Metabolism Journal.2025; 49(3): 403.     CrossRef
• Exploring the Vertical Transmission of Exosomes in Diagnostic and Therapeutic Targets for Pregnancy Complications
  Shrikrishna Bhagat, Rakshith Hanumanthappa, Ketki Bhokare, Neelabh Datta, Nidhi Vastrad, M. David, N. Maharaj, Krishnan Anand
  ACS Biomaterials Science & Engineering.2025; 11(9): 5157.     CrossRef
• Prevalence of Cardiovascular Functional Anomalies in Large-for-Gestational-Age (LGA) Fetuses by Fetal Echocardiography
  Łucja Hanna Biały, Oskar Sylwestrzak, Julia Murlewska, Łukasz Sokołowski, Iwona Strzelecka, Maria Respondek-Liberska
  Journal of Clinical Medicine.2025; 14(13): 4500.     CrossRef
• The Relationship Between Gestational Diabetes, Emotional Eating, and Clinical Indicators
  Tuğçe Taşar Yıldırım, Çiğdem Akçabay, Sevler Yıldız, Gülşen Kutluer
  Medicina.2025; 61(8): 1447.     CrossRef
• Characteristics of the gut microbiota in gestational diabetes mellitus associated with poor dietary habits: An observational study
  Linhua Hu, Hongli Liu, Fengbing Liang, Zhi Du, Shudan Jiang, Guoxia Chen, Xiaoting Fang, Lixia Bi
  Medicine.2025; 104(33): e43752.     CrossRef
• Neurodevelopmental trajectories in well-controlled gestational diabetes mellitus offspring: No differences were found at the 6- and 12-month assessments
  Jing Peng, Huazhang Miao, Li Zhang, Jing Jin, Lirong He, Dongdong Xue, Yong Guo, Guocheng Liu
  Frontiers in Endocrinology.2025;[Epub]     CrossRef
• Activation of GPR39 Ameliorates Placental Dysfunction by Inhibiting Activation of NLRP1 Inflammasome in Gestational Diabetes Mellitus
  Xiaohua Zhou, Hong Sun
  Clinical and Experimental Pharmacology and Physiology.2025;[Epub]     CrossRef
• Early spontaneous movements in full-term infants exposed to gestational diabetes mellitus
  Büşra Kepenek-Varol, Osman Baştuğ, Ahmet Özdemi̇r, Özlem Menevşe
  Infant Behavior and Development.2025; 81: 102156.     CrossRef
• Diagnostic performance of PAPP-A and β-hCG in early detection of gestational diabetes mellitus: a meta-analysis
  Maryam Rahimi, Ladan Haghighi, Mostafa Majidnia, Babak Ghadirzadeh, Yousef Moradi
  Acta Diabetologica.2025; 63(3): 435.     CrossRef
• Chrononutrition in Gestational Diabetes: Toward Precision Timing in Maternal Care
  Viktoria Xega, Jun-Li Liu
  Journal of Personalized Medicine.2025; 15(11): 534.     CrossRef
• Protective effects of berberine-loaded chitosan/solid lipid nanoparticles in streptozotocin-induced gestational diabetes mellitus rats
  Yu Liu, Shaik Althaf Hussain, Hua Yue
  Experimental Biology and Medicine.2025;[Epub]     CrossRef
• The Characteristics of Course of Pregnancy and Perinatal Outcomes in Women with Gestation Diabetes Mellitus (The Results of Ten-Years Research)
  N. V. Batrak, I. V. Ivanova
  Problems of Social Hygiene, Public Health and History of Medicine.2025; 33(6): 1414.     CrossRef
• Is metformin therapy in conjunction with lifestyle modifications more effective than lifestyle modifications alone in lowering the risk of gestational diabetes mellitus in pregnant women with metabolic dysfunction-associated steatotic liver disease (MASLD
  Venkatachalam Jayaseelan, Murali Subbaiah, Kalaiselvy Arikrishnan, Ramkumar Govindarajalu, Sabita Pulavarthi, Nivedita Nanda, Khadeeja Nasreen Vadakkepeediyakkal, Pazhanivel Mohan, Gayathri Murugesan Sivagurunathan, Mohammed Kais Musthafa, Mahadevan Durai
  BMJ Open.2025; 15(12): e093417.     CrossRef
• Pathological mechanisms of gestational diabetes mellitus development
  Hanna Salivon
  InterConf.2025; (62(268)): 130.     CrossRef

Citations

Citations to this article as recorded by  

• Metabolome contribution to sex differences in the link between alcohol consumption and type 2 diabetes: a prospective analysis in the Hispanic Community Health Study/Study of Latinos
  Brian Wang, Kai Luo, Wenyan Ma, Yanbo Zhang, Christina Cordero, Amber Pirzada, Martha Daviglus, Krista M Perreira, Bing Yu, Eric Boerwinkle, Robert C Kaplan, Qibin Qi
  The American Journal of Clinical Nutrition.2026; 123(3): 101203.     CrossRef
• Taurine is a natural suppressor of urea cycle via targeting ASL
  Keqiang Rao, Ke Zheng, Yunfan Sun, Jing He
  Cell Death Discovery.2026;[Epub]     CrossRef
• Reprogramming Metabolic Dysfunction in Diabetes: The emerging role of Taurine from molecular mechanisms to clinical translation
  Shrushti Ambade, Siddhi S. Sandekar, Radheshyam T. Lohiya, Swati N. Lade, Diksha S. Undirwade, Milind J. Umekar, Sushil S. Burle, Aarti S. Zanwar
  Obesity Medicine.2026; : 100713.     CrossRef
• Enhancing metformin efficacy with cholecalciferol and taurine in diabetes therapy: Potential and limitations
  Gehan El-Akabawy, Nabil Eid
  World Journal of Diabetes.2025;[Epub]     CrossRef
• Integrative analysis of taurine metabolism-related genes prognostic signature with immunotherapy and identification of ABCB1 and GORASP1 as key genes in nasopharyngeal carcinoma
  Zhang Feng, Yuhang Yang, Wenqi Luo, Jinqing Li, Zhenlian Xie, Long Zuo, Meijiao Duan, Dongzhi Zuo, Ruwei MO, Xuejing Tang, Shijiang Yi, Xiaosong He, Fangxian Liu, Ning Ma, Feng He
  Amino Acids.2025;[Epub]     CrossRef
• Metabolomics: Uncovering Insights into Obesity and Diabetes
  Mansor Fazliana, Tikfu Gee, Shu Yu Lim, Poh Yue Tsen, Zubaidah Nor Hanipah, Nur Azlin Zainal Abidin, Tan You Zhuan, Farah Huda Mohkiar, Liyana Ahmad Zamri, Haron Ahmad, Mohd Shazli Draman, Noorizatul Syahira Yusaini, Mohd Naeem Mohd Nawi
  International Journal of Molecular Sciences.2025; 26(13): 6216.     CrossRef
• Do Sex and Gender Interact with the Biological Actions of Taurine? A Critical Rereading of the Literature
  Giuseppe Seghieri, Ilaria Campesi, Giancarlo Tonolo, Federico Bennardini, Isabella Stendardi, Rosanna Matucci, Flavia Franconi
  International Journal of Molecular Sciences.2025; 26(16): 8097.     CrossRef
• The Effects of Taurine on Energy Homeostasis and Health: A Nutritional Perspective
  İrem Dağoğlu Polat, Özlem Baran
  Turkish Journal of Diabetes and Obesity.2025; 9(2): 136.     CrossRef
• Effects of Oral Taurine Supplementation on Cardiometabolic Risk Factors: A Meta-analysis and Systematic Review of Randomized Clinical Trials
  Zizheng Nie, Yingying Liu, Mu Zhang, Chenyang Wu, Qinglong Cao, Jiaoyang Xu, Yiren Zheng, Zixin Min, Weiguo Zhang, Shufen Han
  Nutrition Reviews.2025;[Epub]     CrossRef
• Long-term supplementation of taurine induces hepatic steatosis and disrupts bile acid homeostasis in male mice
  Tong Shi, Shu-Yun Zhang
  Toxicology Letters.2025; 414: 111778.     CrossRef
• DiaNat-DB-v2: A Molecular Database of Antidiabetic Compounds from Medicinal Plants and Functional Foods
  Nancy De Jesús-Reyes, Jimena García-Vázquez, Juan F. Avellaneda-Tamayo, David Ramírez-Palma, Mehdi D. Davari, Abraham Madariaga-Mazón, Berenice Ovalle-Magallanes, José L. Medina-Franco, Karina Martinez-Mayorga
  ACS Omega.2025;[Epub]     CrossRef
• Effect of a Very Low-Calorie Diet on Oxidative Stress, Inflammatory and Metabolomic Profile in Metabolically Healthy and Unhealthy Obese Subjects
  Neus Bosch-Sierra, Carmen Grau-del Valle, Christian Salom, Begoña Zaragoza-Villena, Laura Perea-Galera, Rosa Falcón-Tapiador, Susana Rovira-Llopis, Carlos Morillas, Daniel Monleón, Celia Bañuls
  Antioxidants.2024; 13(3): 302.     CrossRef
• Association of Firmicutes/Bacteroidetes Ratio with Body Mass Index in Korean Type 2 Diabetes Mellitus Patients
  Kainat Ahmed, Ha-Neul Choi, Sung-Rae Cho, Jung-Eun Yim
  Metabolites.2024; 14(10): 518.     CrossRef
• Spatial Metabolomics Reveals the Effects of Dietary Capsaicin Intervention on Interscapular Adipose Tissue Metabolome in Mice
  Haoqing Yang, Peiying Zheng, Jiamiao Hu, Zhongjing Lin, Natthida Sriboonvorakul, Shaoling Lin
  Foods.2024; 13(23): 3943.     CrossRef

Citations

Citations to this article as recorded by  

• Early subcutaneous basal insulin with intravenous insulin infusion for diabetic ketoacidosis management: A systematic review and meta‐analysis of randomised controlled trials
  Kitti Thammakosol, Patteera Vongtangton, Pawin Numthavaj, Arunrat Auttara‐atthakorn, Chutintorn Sriphrapradang
  Diabetes, Obesity and Metabolism.2026; 28(2): 1036.     CrossRef
• 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026
  Mandeep Bajaj, Rozalina G. McCoy, Kirthikaa Balapattabi, Raveendhara R. Bannuru, Natalie J. Bellini, Allison K. Bennett, Elizabeth A. Beverly, Kathaleen Briggs Early, Sathyavathi ChallaSivaKanaka, Andjela Drincic, Justin B. Echouffo-Tcheugui, Brendan M. E
  Diabetes Care.2026; 49(Supplement): S339.     CrossRef
• RSSDI clinical practice guidelines for the management of hyperglycemia in hospitalized patients (2025)
  Manoj Chawla, Vijay Viswanathan, Sanjay Agarwal, Anuj Maheshwari, Rakesh Sahay, Pratap Jethwani, Sujoy Ghosh, Sunil Gupta, Nishant Kanodia, A. G. Unnikrishnan, Abhay Kumar Sahoo, Vijaya Kumar, Purvi Chawla, Aravinda Jagadeesha
  International Journal of Diabetes in Developing Countries.2026;[Epub]     CrossRef
• 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2025
  Nuha A. ElSayed, Rozalina G. McCoy, Grazia Aleppo, Kirthikaa Balapattabi, Elizabeth A. Beverly, Kathaleen Briggs Early, Dennis Bruemmer, Justin B. Echouffo-Tcheugui, Laya Ekhlaspour, Rodolfo J. Galindo, Rajesh Garg, Kamlesh Khunti, Rayhan Lal, Ildiko Ling
  Diabetes Care.2025; 48(Supplement): S321.     CrossRef
• Evaluation of hyperglycaemic emergency admissions to a major tertiary centre over a two‐year period
  Serena Chong, Hannah Rubinstein, Tang Wong, Ann Poynten
  Diabetic Medicine.2025;[Epub]     CrossRef
• 2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association
  Shinae Kang, Seon Mee Kang, Jong Han Choi, Seung-Hyun Ko, Bo Kyung Koo, Hyuk-Sang Kwon, Mi Kyung Kim, Sang Yong Kim, Soo-Kyung Kim, Young-eun Kim, Eun Sook Kim, Jae Hyeon Kim, Chong Hwa Kim, Ji Min Kim, Hae Jin Kim, Min Kyong Moon, Sun Joon Moon, Jun Sung
  Diabetes & Metabolism Journal.2025; 49(4): 582.     CrossRef
• Effectiveness and Safety of Early Insulin Glargine U100 and Glargine U300 Administration in the Management of Diabetic Ketoacidosis in Adults With Type 1 Diabetes Mellitus: A Randomized Clinical Trial
  Amr Y. El Feky, Marwa S. Abdou, Rania Naguib, Samar F. Abdelsalam, Mohamed Hamdy, Shimaa M. Elrahmany
  Endocrine Practice.2025; 31(12): 1554.     CrossRef
• Early vs. late initiation of long-acting basal insulin during IV insulin in pediatric diabetic ketoacidosis: a GRADE-assessed systematic review and meta-analysis
  Asim Shah, Asad Jamal, Maria Qadri, Muhammad Jibran Afridi, Suleman Khan, Zaryab Bacha, Adil Nawaz, Hammad Iftikhar, Misbah Uddin, Aizaz Anwar Khalid
  European Journal of Pediatrics.2025;[Epub]     CrossRef
• 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2024
  Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, Dennis Bruemmer, Billy S. Collins, Laya Ekhlaspour, Rodolfo J. Galindo, Marisa E. Hilliard, Eric L. Johnson, Kamlesh Khunti, Ildiko Lingvay, Glenn Matfin, Rozalina G. McCoy, Mary Lou Perry, Scott J.
  Diabetes Care.2024; 47(Supplement): S295.     CrossRef
• Retrospective Comparison of Early Versus Late Initiation of Long-Acting Insulin in Critically Ill Pediatric Patients in Diabetic Ketoacidosis
  Emily S. Cormack, Amber Howard, Derrick Eddy, Nick Schulte
  The Journal of Pediatric Pharmacology and Therapeutics.2024; 29(6): 614.     CrossRef
• 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2023
  Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, Jose Leon, Sarah K. Lyons, Mary Lou Perry, Priya
  Diabetes Care.2023; 46(Supplement): S267.     CrossRef
• Effectiveness and safety of early insulin glargine administration in combination with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: A randomized controlled trial
  Kitti Thammakosol, Chutintorn Sriphrapradang
  Diabetes, Obesity and Metabolism.2023; 25(3): 815.     CrossRef

Citations

Citations to this article as recorded by  

• Impact of Vitamin D deficiency and VDR FokI polymorphism on diabetic nephropathy risk in type 2 diabetes
  Addisu Melake, Misganaw Asmamaw Mengstie
  Journal of the National Medical Association.2026; 118(1): 83.     CrossRef
• Association between triglyceride-glucose index and diabetic kidney disease in adults with type 1 diabetes
  Jie Xiang, Wei Gao, Yao Yao, Chan Lu
  BMC Endocrine Disorders.2026;[Epub]     CrossRef
• Role of vitamin D3 in lipid metabolism and chronic pain in advanced diabetic kidney disease and its rehabilitation
  Ning-Ning Zhuang, Hao-Jun You
  Healthcare and Rehabilitation.2025; 1(1): 100005.     CrossRef
• Role of platelet indices and vitamin D in forecasting deterioration of glycemic control and vascular complications in type 2 diabetes
  Maryam Ahmed Obaid Al Ali, Khalid Abdelsamea Mohamedahmed, Asaad Ma Babker
  Italian Journal of Medicine.2025;[Epub]     CrossRef
• Vitamin D Status and Its Association With Sun Exposure in Patients With Type 2 Diabetes Mellitus in Southern Malaysia
  Norizzati Amsah, Zaleha Md Isa, Norfazilah Ahmad, Zaid Kassim, Siti Nor Athirah Mohamad
  Cureus.2025;[Epub]     CrossRef
• Impact of dioxins and polychlorinated biphenyls on kidney parameters: The modulatory role of vitamin D
  Dongdong Zhang, Xixi Qiao, Juan Peng, Jingjing Quan, Zhijun Huang, Bin Yi
  Ecotoxicology and Environmental Safety.2025; 294: 118062.     CrossRef
• Vitamin D deficiency and VDR TaqI polymorphism on diabetic nephropathy risk among type 2 diabetes patients
  Addisu Melake, Misganaw Asmamaw Mengstie
  Frontiers in Endocrinology.2025;[Epub]     CrossRef
• Role of vitamin D in the development and progression of diabetic kidney disease: an overview of meta-analyses
  Ashna Chackochan, Muhammed Rashid, Swetha R. Reghunath, Pooja Gopal Poojari, Girish Thunga, Shivashankara Kaniyoor Nagri, Vasudeva Guddattu, Revathi P. Shenoy, Vishnu Prasad Shenoy, Leelavathi D. Acharya
  Therapeutic Advances in Endocrinology and Metabolism.2025;[Epub]     CrossRef
• Association Between Vitamin D Receptor Gene Polymorphism and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus
  Nardin S. Soliman, Dina Adam El-Shahat, Hala Mohammed Nagy, Gihan Farouk Attia, Amal Abd Elmoniem Selim
  Indian Journal of Clinical Biochemistry.2025;[Epub]     CrossRef
• 25-(OH)D Deficiency and the Risk of Minor Amputation in Patients with Diabetes Foot Ulcers: A Chinese Cohort Study
  Zhikai Qian, Yongyang Sun, Jinyu Bai, Bo Jiang, Jiaju Zhao
  International Journal of General Medicine.2025; Volume 18: 3837.     CrossRef
• Associations between serum JAML, nesfatin-1, and 25(OH)D and the risk of diabetic kidney disease in patients with type 2 diabetes
  Qizhuo Hou, Kangkang Huang, Yunlai Liang, Wenze Yu, Lu Long, Kun Wang, Bin Yi
  Scientific Reports.2025;[Epub]     CrossRef
• Vitamin D Deficiency Is Associated with an Increased Risk of Macroalbuminuria in Chinese Patients with Type 2 Diabetes
  Xiulin WANG, Wenjin XIAO
  Journal of Nutritional Science and Vitaminology.2025; 71(4): 283.     CrossRef
• Association of Vitamin D Deficiency with Diabetic Nephropathy in Type 2 Diabetes: A Hospital-Based Cross-Sectional Study
  Shafia Bashir, Geer Mohammad Ishaq, Insha Mushtaq, Mohammad Ashraf Ganie, Imtiyaz Wani, Muteb Alanazi, Ibrahim Asiri, Arshad Hussain, Kashif Ullah Khan, Sirajudheen Anwar
  Diseases.2025; 13(12): 405.     CrossRef
• Association Between Vitamin D and Diabetic Kidney Disease
  Feride Pınar Altay, Özlem Turhan İyidir, Sevim Güllü
  Journal of Clinical Medicine.2025; 15(1): 153.     CrossRef
• Evaluation the Levels of Pentosidine and Vitamin D3 in Diabetic Nephropathy
  Maryam Hiyder Kadum, Khawla A. Shemran, Yasameen AL Saffar
  Medical Journal of Babylon.2025; 22(4): 995.     CrossRef
• Deficiency of 25-Hydroxy Vitamin D in Type 2 Diabetic Patients in Parakou in 2023: Prevalence and Associated Factors
  Moutawakilou Gomina, Adébayo Alassani, Diane Naissem Guidimbaye, Sékossounon Sanni, Romaric Basson, Jean-Baptiste Aidjinou, Lassane Zoungrana, Abdou-Badiou Djibril, Jules Gninkoun
  Open Journal of Endocrine and Metabolic Diseases.2025; 15(10): 217.     CrossRef
• ED-71 ameliorates bone regeneration in type 2 diabetes by reducing ferroptosis in osteoblasts via the HIF1α pathway
  Maoshan Wang, Yingxue Liu, Houda Gui, Gaoqiang Ma, Binyang Li, Zhanwei Zhang, Gyeonghwi Yu, Ailin Wu, Xin Xu, Dongjiao Zhang
  European Journal of Pharmacology.2024; 969: 176303.     CrossRef
• Vitamin D metabolism in diabetic nephropathy
  Z. V. Abilov, R. Kh. Salimkhanov, A. A. Povaliaeva, A. Yu. Zhukov, E. A. Pigarova, L. K. Dzeranova, L. Ya. Rozhinskaya
  Obesity and metabolism.2024; 20(4): 283.     CrossRef
• Telmisartan ameliorates nephropathy and restores the hippo pathway in rats with metabolic syndrome
  Badria Mohamed, Salah A. Ghareib, Amira Ebrahim Alsemeh, Shaimaa S. El-Sayed
  European Journal of Pharmacology.2024; 973: 176605.     CrossRef
• The impact of vitamin D on the etiopathogenesis and the progression of type 1 and type 2 diabetes in children and adults
  Candong Li, Jiaowen Fu, Yipeng Ye, Junsen Li, Yangli He, Tuanyu Fang
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• 25(OH)D level and vascular lesion scores in kidney histopathology as risk-stratification tool for predicting renal progression in people with type 2 diabetes
  Suyan Duan, Fang Lu, Rui Sun, Chen Chen, Si Chen, Luhan Geng, Li Qian, Ying Pan, Chengning Zhang, Ming Zeng, Bin Sun, Huijuan Mao, Bo Zhang, Changying Xing, Yanggang Yuan
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2024; 18(5): 103037.     CrossRef
• Relationship between bone turnover markers and renal disease in elderly patients with type 2 diabetes: a cross-sectional study
  Shuwu Wei, Xinyu Pan, Junping Wei
  BMC Endocrine Disorders.2024;[Epub]     CrossRef
• COVID-19 infection and metabolic comorbidities: Mitigating role of nutritional sufficiency and drug – nutraceutical combinations of vitamin D
  Sumit Kumar Mandal, Meghana Tare, P.R. Deepa
  Human Nutrition & Metabolism.2023; 31: 200179.     CrossRef
• Effects of Vitamin D Supplementation in Diabetic Kidney Disease: A Systematic Review
  Thais de Oliveira e Silva Ullmann, Beatrys Juliani Ramalho, Lucas Fornari Laurindo, Ricardo José Tofano, Claudio José Rubira, Elen Landgraf Guiguer, Sandra Maria Barbalho, Uri Adrian Prync Flato, Katia Portero Sloan, Adriano Cressoni Araujo
  Journal of Renal Nutrition.2023; 33(5): 618.     CrossRef
• Diabetic Nephropathy: Significance of Determining Oxidative Stress and Opportunities for Antioxidant Therapies
  Marina Darenskaya, Sergey Kolesnikov, Natalya Semenova, Lyubov Kolesnikova
  International Journal of Molecular Sciences.2023; 24(15): 12378.     CrossRef
• Association between serum 25- hydroxyvitamin D and albuminuiria in middle-aged and older Chinese patients with type 2 diabetes
  Luyan Zhang, Qian Guo, Yanjia Xu, Wenzhen Wei, Yu Wang
  BMC Endocrine Disorders.2023;[Epub]     CrossRef
• Vitamin D deficiency and its associated factors among patients with type 2 diabetes mellitus: a systematic review and meta-analysis
  Mitku Mammo Taderegew, Gashaw Garedew Woldeamanuel, Alemayehu Wondie, Atsede Getawey, Abera Nesiru Abegaz, Fentahun Adane
  BMJ Open.2023; 13(10): e075607.     CrossRef
• Progression of diabetic nephropathy and vitamin D serum levels: A pooled analysis of 7722 patients
  Yomna E. Dean, Sameh Samir Elawady, Wangpan Shi, Ahmed A. Salem, Arinnan Chotwatanapong, Haya Ashraf, Tharun Reddi, Prashant Obed Reddy Dundi, Waleed Yasser Habash, Mohamed Yasser Habash, Safaa Ahmed, Hana M. Samir, Ahmed Elsayed, Aryan Arora, Abhinav Aro
  Endocrinology, Diabetes & Metabolism.2023;[Epub]     CrossRef
• Incidence of Vitamin D Deficiency and Its Association With Microalbuminuria in Patients With Type 2 Diabetes Mellitus
  Muhammad Hamza Riaz, Ammar Jamil, Hira Yousaf, Muhammad Hassan, Muhammad Ahmer Sohaib, Sharjeel Babar, Muhammad Hassan Ahmad, Ibtesam Allahi, Muhammad Zeshan Mehmood, Tayyab Mumtaz Khan
  Cureus.2023;[Epub]     CrossRef
• The Role of Vitamin D in Diabetic Nephropathy: A Translational Approach
  Charlotte Delrue, Reinhart Speeckaert, Joris R. Delanghe, Marijn M. Speeckaert
  International Journal of Molecular Sciences.2022; 23(2): 807.     CrossRef
• Associations of serum amyloid A and 25‐hydroxyvitamin D with diabetic nephropathy: A cross‐sectional study
  Qian Liu, Jin Sun, Tongdao Xu, Guangrong Bian, Fumeng Yang
  Journal of Clinical Laboratory Analysis.2022;[Epub]     CrossRef
• Formulation Strategies for Improving the Stability and Bioavailability of Vitamin D-Fortified Beverages: A Review
  Elsa F. Vieira, Suene Souza
  Foods.2022; 11(6): 847.     CrossRef
• Association between Vitamin D Status and Mortality among Adults with Diabetic Kidney Disease
  Feng Xu, Hongyu Lu, Tianwen Lai, Ling Lin, Yongsong Chen, Pratibha V. Nerurkar
  Journal of Diabetes Research.2022; 2022: 1.     CrossRef
• Assessment of the relationship between 25-hydroxyvitamin D and albuminuria in type 2 diabetes mellitus
  Seyed Alireza Zomorodian, Maryam Shafiee, Zeinab Karimi, Fatemeh Masjedi, Amirhossein Roshanshad
  BMC Endocrine Disorders.2022;[Epub]     CrossRef
• Association of Serum 25 (OH) Vitamin D With Chronic Kidney Disease Progression in Type 2 Diabetes
  Suyan Duan, Fang Lu, Buyun Wu, Chengning Zhang, Guangyan Nie, Lianqin Sun, Zhimin Huang, Honglei Guo, Bo Zhang, Changying Xing, Yanggang Yuan
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• The Influence of Dietary Supplementations on Neuropathic Pain
  Francesco D’Egidio, Giorgia Lombardozzi, Housem E. Kacem Ben Haj M’Barek, Giada Mastroiacovo, Margherita Alfonsetti, Annamaria Cimini
  Life.2022; 12(8): 1125.     CrossRef
• Emergence of Ectopic Adrenal Tissues-What are the Probable Mechanisms?
  Gürkan Tarçın, Oya Ercan
  Journal of Clinical Research in Pediatric Endocrinology.2022; 14(3): 258.     CrossRef
• Anti-proteinuria effect of active vitamin D in patients with type 2 diabetic nephropathy
  Asieh Aref, Mina Khodhal, Homeira Rashidi, Zahra Farhangiyan, Saeid Bitaraf
  Journal of Family Medicine and Primary Care.2022; 11(12): 7735.     CrossRef
• Nutritional Supplements for the Treatment of Neuropathic Pain
  Khaled M. Abdelrahman, Kevin V. Hackshaw
  Biomedicines.2021; 9(6): 674.     CrossRef
• Vitamin D Deficiency as a Predictor of a High Prevalence of Coronary Artery Disease in Pancreas Transplant Candidates With Type 1 Diabetes
  Małgorzata Buksińska-Lisik, Przemysław J. Kwasiborski, Robert Ryczek, Wojciech Lisik, Artur Mamcarz
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Serum 25-hydroxyvitamin D and Metabolic Parameters in Healthy Korean Adults: Korean National Health and Nutrition Examination Survey VI
  Jeonghoon Ha, Hansang Baek, Chaiho Jeong, Hyunsam Kim, Ki-Hyun Baek, Moo Il Kang, Dong-Jun Lim
  International Journal of General Medicine.2021; Volume 14: 5233.     CrossRef
• Association Between 25(OH)Vitamin D, HbA1c and Albuminuria in Diabetes Mellitus: Data From a Population-Based Study (VIDAMAZON)
  João Soares Felício, Hana Andrade de Rider Britto, Pedro Celeira Cortez, Fabrício de Souza Resende, Manuela Nascimento de Lemos, Lorena Vilhena de Moraes, Vitória Teixeira de Aquino, Fernanda de Souza Parente, Natércia Neves Marques de Queiroz, João Felíc
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Vitamin D Analogs Can Retard the Onset or Progression of Diabetic Kidney Disease: A Systematic Review
  Samuel N. Uwaezuoke
  Frontiers in Clinical Diabetes and Healthcare.2021;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Evidence of Overlapping Roles Between Clinics and Hospitals in Primary Care
  Boram Sim, Jihye Shin, Hyun Woo Kim, Jin Yong Lee, Min-Woo Jo
  Journal of Korean Medical Science.2025;[Epub]     CrossRef
• Efficacy and safety in tirzepatide‐treated Korean adults with type 2 diabetes—A post hoc analysis of SURPASS‐AP‐combo and SURPASS‐3
  Byung Wan Lee, Chang Beom Lee, Soo Lim, Sin Gon Kim, Nan Hee Kim, Jong Chul Won, Woo Je Lee, Min Ju Kang, Ju Young Yuh, Li Ying Du, Hyojin Lim, Kyu Jeung Ahn
  Diabetes, Obesity and Metabolism.2025; 27(12): 7110.     CrossRef
• Digital Healthcare and Diabetic Retinopathy: Patient Experience Innovation and Support for Diabetes Care
  Sang Jun Park
  The Journal of Korean Diabetes.2025; 26(4): 208.     CrossRef
• A mixed-method study on the screening practices and barriers to diabetic microvascular complications by general practitioners in community health centers of Xiamen, China
  Zhang-Yan Chen, Cui-Ling Huang, Cheng-Dian Lan, Hua Yang
  BMC Primary Care.2025;[Epub]     CrossRef
• Efficacy and Safety of Pioglitazone/Metformin Fixed-Dose Combination Versus Uptitrated Metformin in Patients with Type 2 Diabetes without Adequate Glycemic Control: A Randomized Clinical Trial
  Li-xin Guo, Lian-wei Wang, De-zeng Tian, Feng-mei Xu, Wei Huang, Xiao-hong Wu, Wei Zhu, Jun-Qiu Chen, Xin Zheng, Hai-Yan Zhou, Hong-Mei Li, Zhong-Chen He, Wen-Bo Wang, Li-Zhen Ma, Jun-Ting Duan
  Diabetes Therapy.2024; 15(11): 2351.     CrossRef
• Analytical techniques for determination of metformin-thiazolidinediones combination antidiabetic drug
  Imad Osman Abu Reid, Sayda Mohamed Osman, Somia Mohammed Bakheet
  Journal of Pharmacy and Allied Medicine.2024; 2(2): 82.     CrossRef
• Risk of Cause-Specific Mortality across Glucose Spectrum in Elderly People: A Nationwide Population-Based Cohort Study
  Joonyub Lee, Hun-Sung Kim, Kee-Ho Song, Soon Jib Yoo, Kyungdo Han, Seung-Hwan Lee
  Endocrinology and Metabolism.2023; 38(5): 525.     CrossRef
• Comparison of on-Statin Lipid and Lipoprotein Levels for the Prediction of First Cardiovascular Event in Type 2 Diabetes Mellitus
  Ji Yoon Kim, Jimi Choi, Sin Gon Kim, Nam Hoon Kim
  Diabetes & Metabolism Journal.2023; 47(6): 837.     CrossRef
• Effectiveness of quality of care for patients with type 2 diabetes in China: findings from the Shanghai Integration Model (SIM)
  Chun Cai, Yuexing Liu, Yanyun Li, Yan Shi, Haidong Zou, Yuqian Bao, Yun Shen, Xin Cui, Chen Fu, Weiping Jia
  Frontiers of Medicine.2022; 16(1): 126.     CrossRef
• Comparison of Health Outcomes by Care Provider Type for Newly Diagnosed Mild Type 2 Diabetes Patients in South Korea: A Retrospective Cohort Study
  Hee-Chung Kang, Jae-Seok Hong
  Healthcare.2022; 10(2): 334.     CrossRef
• Management Status of Patients with Type 2 Diabetes Mellitus at General Hospitals in Korea: A 5-Year Follow-Up Study
  Jin Hee Jung, Jung Hwa Lee, Hyang Mi Jang, Young Na, Hee Sun Choi, Yeon Hee Lee, Yang Gyo Kang, Na Rae Kim, Jeong Rim Lee, Bok Rye Song, Kang Hee Sim
  The Journal of Korean Diabetes.2022; 23(1): 64.     CrossRef
• Type 2 Diabetes Mellitus with Early Dry Skin Disorder: A Comparison Study Between Primary and Tertiary Care in Indonesia
  Lili Legiawati, Kusmarinah Bramono, Wresti Indriatmi, Em Yunir, Aditya Indra Pratama
  Current Diabetes Reviews.2022;[Epub]     CrossRef
• Long-Term Changes in HbA1c According to Blood Glucose Control Status During the First 3 Months After Visiting a Tertiary University Hospital
  Hyunah Kim, Da Young Jung, Seung-Hwan Lee, Jae-Hyoung Cho, Hyeon Woo Yim, Hun-Sung Kim
  Journal of Korean Medical Science.2022;[Epub]     CrossRef
• Differences in health behavior and nutrient intake status between diabetes-aware and unaware Korean adults based on the Korea national health and nutrition examination survey 2016–18 data: A cross-sectional study
  Anshul Sharma, Chen Lulu, Kee-Ho Song, Hae-Jeung Lee
  Frontiers in Public Health.2022;[Epub]     CrossRef
• Effects of Diabetes Quality Assessment on Diabetes Management Behaviors Based on a Nationwide Survey
  Chang Kyun Choi, Jungho Yang, Ji-An Jeong, Min-Ho Shin
  International Journal of Environmental Research and Public Health.2022; 19(23): 15781.     CrossRef
• The Impact of the Indonesian Chronic Disease Management Program (PROLANIS) on Metabolic Control and Renal Function of Type 2 Diabetes Mellitus Patients in Primary Care Setting
  Firas Farisi Alkaff, Fauzan Illavi, Sovia Salamah, Wiwit Setiyawati, Ristra Ramadhani, Elly Purwantini, Dicky L. Tahapary
  Journal of Primary Care & Community Health.2021;[Epub]     CrossRef
• Questionnaire-based Survey of Demographic and Clinical Characteristics, Health Behaviors, and Mental Health of Young Korean Adults with Early-Onset Diabetes
  Ji In Park, Hyunjeong Baek, Sang-Wook Kim, Ji Yun Jeong, Kee-Ho Song, Ji Hee Yu, Il Sung Nam-Goong, Eun-Hee Cho
  Journal of Korean Medical Science.2021;[Epub]     CrossRef
• Sodium–Glucose Cotransporter 2 Inhibitors and Risk of Retinal Vein Occlusion Among Patients With Type 2 Diabetes: A Propensity Score–Matched Cohort Study
  Min-Kyung Lee, Bongsung Kim, Kyungdo Han, Jae-Hyuk Lee, Minhee Kim, Mee Kyoung Kim, Ki-Hyun Baek, Ki-Ho Song, Hyuk-Sang Kwon, Young-Jung Roh
  Diabetes Care.2021; 44(10): 2419.     CrossRef
• Challenges in the Management of Diabetes in Primary Care
  Yeon Kyung Lee
  The Journal of Korean Diabetes.2020; 21(3): 161.     CrossRef
• Does Diabetes Increase the Risk of Contracting COVID-19? A Population-Based Study in Korea
  Sung-Youn Chun, Dong Wook Kim, Sang Ah Lee, Su Jung Lee, Jung Hyun Chang, Yoon Jung Choi, Seong Woo Kim, Sun Ok Song
  Diabetes & Metabolism Journal.2020; 44(6): 897.     CrossRef
• Comprehensive Efforts Are Needed to Improve the Quality of Primary Diabetes Care in Korea
  Chan-Hee Jung
  Endocrinology and Metabolism.2019; 34(3): 265.     CrossRef

Citations

Citations to this article as recorded by  

• Real-World Evidence for Metformin Use in Solid Organ Transplant Recipients Living With Diabetes
  Idit Dotan, Shiri Kushnir, Tzippy Shochat, Talia Diker Cohen
  Endocrine Practice.2026; 32(3): 360.     CrossRef
• Gene Expression as a Guide for the Development of Novel Therapies in Hypertensive and Diabetic Kidney Disease
  Maria Zaimi, Georgios Zagkotsis, Athanasios Kammenos, Eirini Grapsa, Smaragdi Marinaki, Eleni Frangou
  Journal of Clinical Medicine.2026; 15(2): 696.     CrossRef
• Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy (EFFORT): A 24‐week, randomized, open‐label, multicenter trial
  So Ra Kim, Jun Hwa Hong, Sin Gon Kim, Soo‐Kyung Kim, Hyuk‐Sang Kwon, Jun Sung Moon, Jung Hwan Park, Jae Myung Yu, Bong‐Soo Cha, Byung‐Wan Lee
  Diabetes, Obesity and Metabolism.2026; 28(4): 3305.     CrossRef
• Positive impact of DPP-4 or SGLT2 inhibitors on mild cognitive impairment in type 2 diabetes patients on metformin therapy: A metabolomic mechanistic insight
  Shams T. Osman, Waziha Purba, Oluwatosin Daramola, Md Mostofa Al Amin Bhuiyan, Judith Nwaiwu, Mojibola Fowowe, Junyao Wang, Noha A. Hamdy, Mahmoud A. Agami, Amr Y. El-Feky, Labiba K. El-Khordagui, Yehia S. Mechref, Ahmed F. El-Yazbi
  Biomedicine & Pharmacotherapy.2025; 182: 117771.     CrossRef
• Use of dipeptidyl peptidase‐4 inhibitors is associated with lower risk of severe renal outcomes in pre‐dialysis patients with Type 2 diabetes
  Tung‐Ying Hung, Tzu‐Chieh Lin, Ying‐Jay Liou, Tzu‐Han Lin, Yu‐Juei Hsu, Liang‐Yu Lin, Meng‐Ting Wang
  Journal of Internal Medicine.2025; 298(3): 214.     CrossRef
• Ipragliflozin and sitagliptin differentially affect lipid and apolipoprotein profiles in type 2 diabetes: the SUCRE study
  Mototsugu Nagao, Jun Sasaki, Kyoko Tanimura-Inagaki, Ichiro Sakuma, Hitoshi Sugihara, Shinichi Oikawa
  Cardiovascular Diabetology.2024;[Epub]     CrossRef
• Repurposing DPP-4 Inhibitors as a Novel Intervention in COVID-19: In Silico Analysis for SARS-CoV-2 Spike Glycoprotein Inhibition
  Chhanda Charan Danta, Manoj Kumar Mahapatra
  Proceedings of the National Academy of Sciences, India Section B: Biological Sciences.2024; 94(3): 635.     CrossRef
• Effect of DPP-4i inhibitors on renal function in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
  Yong Gong, Xueyan Bai, Donglei Zhang, Xingsheng Yang, Zheng Qin, Yu Yang, Yilun Zhou, Jie Meng, Xin Liu
  Lipids in Health and Disease.2024;[Epub]     CrossRef
• Comparison of renal prognosis between dipeptidyl peptidase‐4 inhibitor users and non‐users
  Hideaki Hashimoto, Michihiro Satoh, Shingo Nakayama, Maya Toyama, Takahisa Murakami, Taku Obara, Naoki Nakaya, Takefumi Mori, Atushi Hozawa, Hirohito Metoki
  Diabetes, Obesity and Metabolism.2024; 26(10): 4460.     CrossRef
• Safety and Efficiency of Dipeptidyl Peptidase IV Inhibitors in Patients with Diabetic Kidney Disease: A Systematic Review and Meta-Analysis
  Adili Tuersun, Munire Mohetaer, Guanxin Hou, Gang Cheng
  Current Therapeutic Research.2024; 101: 100763.     CrossRef
• Transforming Diabetes Care: The Expanding Role of DPP-4 Inhibitors in Cardiovascular and Renal Protection
  Francisco Epelde
  Medicina.2024; 60(11): 1793.     CrossRef
• Dulaglutide and Dapagliflozin Combination Concurrently Improves the Endothelial Glycocalyx and Vascular and Myocardial Function in Patients with T2DM and Albuminuria vs. DPP-4i
  Emmanouil Korakas, John Thymis, Evangelos Oikonomou, Konstantinos Mourouzis, Aikaterini Kountouri, Loukia Pliouta, Sotirios Pililis, George Pavlidis, Stamatios Lampsas, Konstantinos Katogiannis, Lina Palaiodimou, Georgios Tsivgoulis, Gerasimos Siasos, Ign
  Journal of Clinical Medicine.2024; 13(24): 7497.     CrossRef
• Effects of glucose‐lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta‐analysis of randomized controlled trials with external adjudication of events
  Edoardo Mannucci, Marco Gallo, Andrea Giaccari, Riccardo Candido, Basilio Pintaudi, Giovanni Targher, Matteo Monami
  Diabetes, Obesity and Metabolism.2023; 25(2): 444.     CrossRef
• Sitagliptin Mitigates Diabetic Nephropathy in a Rat Model of Streptozotocin-Induced Type 2 Diabetes: Possible Role of PTP1B/JAK-STAT Pathway
  Sarah M. AL-Qabbaa, Samaher I. Qaboli, Tahani K. Alshammari, Maha A. Alamin, Haya M. Alrajeh, Lama A. Almuthnabi, Rana R. Alotaibi, Asma S. Alonazi, Anfal F. Bin Dayel, Nawal M. Alrasheed, Nouf M. Alrasheed
  International Journal of Molecular Sciences.2023; 24(7): 6532.     CrossRef
• Take an individualized and multipronged approach when managing older adults with type 2 diabetes
  Sheridan M. Hoy
  Drugs & Therapy Perspectives.2023; 39(5): 171.     CrossRef
• Cardiovascular and Renal Outcomes With Sodium-Glucose Cotransporter-2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors Combination Therapy: A Meta-Analysis of Randomized Cardiovascular Outcome Trials
  Awadhesh Kumar Singh, Akriti Singh, Ritu Singh
  Endocrine Practice.2023; 29(7): 509.     CrossRef
• Sodium‐glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors on new‐onset overall cancer in Type 2 diabetes mellitus: A population‐based study
  Cheuk To Chung, Ishan Lakhani, Oscar Hou In Chou, Teddy Tai Loy Lee, Edward Christopher Dee, Kenrick Ng, Wing Tak Wong, Tong Liu, Sharen Lee, Qingpeng Zhang, Bernard Man Yung Cheung, Gary Tse, Jiandong Zhou
  Cancer Medicine.2023; 12(11): 12299.     CrossRef
• Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes
  Deborah J. Wexler, Ian H. de Boer, Alokananda Ghosh, Naji Younes, Ionut Bebu, Silvio E. Inzucchi, Janet B. McGill, Sunder Mudaliar, David Schade, Michael W. Steffes, William V. Tamborlane, Meng H. Tan, Faramarz Ismail-Beigi, Jill P. Crandall, Melissa Dian
  JAMA Internal Medicine.2023; 183(7): 705.     CrossRef
• SAFETY PROFILE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS
  M. Ganeva
  Trakia Journal of Sciences.2023; 21(1): 54.     CrossRef
• Chronic Kidney Disease and SGLT2 Inhibitors: A Review of the Evolving Treatment Landscape
  Christian W. Mende
  Advances in Therapy.2022; 39(1): 148.     CrossRef
• Management of Hyperglycemia in Older Adults with Type 2 Diabetes
  Gunjan Y. Gandhi, Arshag D. Mooradian
  Drugs & Aging.2022; 39(1): 39.     CrossRef
• Pharmacoeconomic evaluation of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus: a systematic literature review
  Zhen Ruan, Huimin Zou, Qing Lei, Carolina Oi Lam Ung, Honghao Shi, Hao Hu
  Expert Review of Pharmacoeconomics & Outcomes Research.2022; 22(4): 555.     CrossRef
• Effect of Anagliptin versus Sitagliptin on Renal Function: Subanalyzes from the REASON Trial
  Hiroki Teragawa, Takeshi Morimoto, Yuichi Fujii, Tomohiro Ueda, Mio Sakuma, Michio Shimabukuro, Osamu Arasaki, Koichi Node, Takashi Nomiyama, Shinichiro Ueda
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 685.     CrossRef
• Glomerular filtration rate as a kidney outcome of diabetic kidney disease: a focus on new antidiabetic drugs
  Hyo Jin Kim, Sang Soo Kim, Sang Heon Song
  The Korean Journal of Internal Medicine.2022; 37(3): 502.     CrossRef
• The Effects of Dipeptidyl Peptidase 4 Inhibitors on Renal Function in Patients with Type 2 Diabetes Mellitus
  Wan-Chia Hsu, Chun-Sheng Lin, Jung-Fu Chen, Chih-Min Chang
  Journal of Clinical Medicine.2022; 11(9): 2653.     CrossRef
• Treatment of diabetes mellitus has borne much fruit in the prevention of cardiovascular disease
  Hiroaki Yagyu, Hitoshi Shimano
  Journal of Diabetes Investigation.2022; 13(9): 1472.     CrossRef
• Finerenone, a Novel and Safer Approach toward Management of Diabetic Kidney Disease with Heart Failure
  Ayesha Abdul Qadir Memon, Sarmad Iqbal
  Global Journal of Medical, Pharmaceutical, and Biomedical Update.2022; 17: 12.     CrossRef
• The effects of dipeptidyl peptidase‐4 inhibitors on kidney outcomes
  Daniel V. O'Hara, Thomas R. Parkhill, Sunil V. Badve, Min Jun, Meg J. Jardine, Vlado Perkovic
  Diabetes, Obesity and Metabolism.2021; 23(3): 763.     CrossRef
• Urinary DPP4 correlates with renal dysfunction, and DPP4 inhibition protects against the reduction in megalin and podocin expression in experimental CKD
  Acaris Benetti, Flavia Letícia Martins, Letícia Barros Sene, Maria Heloisa M. Shimizu, Antonio C. Seguro, Weverton M. Luchi, Adriana C. C. Girardi
  American Journal of Physiology-Renal Physiology.2021; 320(3): F285.     CrossRef
• Incretin-based drugs and the kidney in type 2 diabetes: choosing between DPP-4 inhibitors and GLP-1 receptor agonists
  Johannes F.E. Mann, Marcel H.A. Muskiet
  Kidney International.2021; 99(2): 314.     CrossRef
• Renoprotective Effects of DPP-4 Inhibitors
  Daiji Kawanami, Yuichi Takashi, Hiroyuki Takahashi, Ryoko Motonaga, Makito Tanabe
  Antioxidants.2021; 10(2): 246.     CrossRef
• Danegaptide Prevents TGFβ1-Induced Damage in Human Proximal Tubule Epithelial Cells of the Kidney
  Paul E. Squires, Gareth W. Price, Ulrik Mouritzen, Joe A. Potter, Bethany M. Williams, Claire E. Hills
  International Journal of Molecular Sciences.2021; 22(6): 2809.     CrossRef
• Comparative Renal Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Cotransporter 2 Inhibitors on Individual Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
  Jae Hyun Bae, Eun-Gee Park, Sunhee Kim, Sin Gon Kim, Seokyung Hahn, Nam Hoon Kim
  Endocrinology and Metabolism.2021; 36(2): 388.     CrossRef
• Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes
  Jack Wei Chieh Tan, David Sim, Junya Ako, Wael Almahmeed, Mark E Cooper, Jamshed J Dalal, Chaicharn Deerochanawong, David Wei Chun Huang, Sofian Johar, Upendra Kaul, Sin Gon Kim, Natalie Koh, Alice Pik-Shan Kong, Rungroj Krittayaphong, Bernard Kwok, Bien
  European Cardiology Review.2021;[Epub]     CrossRef
• Diabetes and kidney disease: emphasis on treatment with SGLT-2 inhibitors and GLP-1 receptor agonists
  Francesco Prattichizzo, Paola de Candia, Antonio Ceriello
  Metabolism.2021; 120: 154799.     CrossRef
• SGLT2 Inhibitors and Other Novel Therapeutics in the Management of Diabetic Kidney Disease
  Robert C. Stanton
  Seminars in Nephrology.2021; 41(2): 85.     CrossRef
• Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
  Nina Vodošek Hojs, Sebastjan Bevc, Robert Ekart, Nejc Piko, Tadej Petreski, Radovan Hojs
  Pharmaceuticals.2021; 14(6): 561.     CrossRef
• Podocyte Glucocorticoid Receptors Are Essential for Glomerular Endothelial Cell Homeostasis in Diabetes Mellitus
  Swayam Prakash Srivastava, Han Zhou, Ocean Setia, Alan Dardik, Carlos Fernandez‐Hernando, Julie Goodwin
  Journal of the American Heart Association.2021;[Epub]     CrossRef
• Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease
  Swayam Prakash Srivastava, Rohit Srivastava, Subhash Chand, Julie E. Goodwin
  Pharmaceuticals.2021; 14(8): 751.     CrossRef
• Effects of DPP4 inhibitors on renal outcomes in diabetes mellitus: A systematic review and meta-analysis
  SaikatK Dalui, Raja Chakraverty, Nafisha Yasmin, Smita Pattanaik, Kaushik Pandit, Suparna Chatterjee
  Indian Journal of Endocrinology and Metabolism.2021; 25(4): 283.     CrossRef
• Comparison of Adverse Kidney Outcomes With Empagliflozin and Linagliptin Use in Patients With Type 2 Diabetic Patients in a Real-World Setting
  Yueh-Ting Lee, Chien-Ning Hsu, Chung-Ming Fu, Shih-Wei Wang, Chiang-Chi Huang, Lung-Chih Li
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• The Role of DPP-4 Inhibitors in Type-2 Diabetes Patients with Chronic Kidney Disease
  Mishal Yousef Alqurashi, Khalid Faisal Alharthi, Abdulaziz Abdulrahman Alshehri, Yazeed Khalid Alharbi, Mohammad Abdulmunem Sanousi, Anas Abdullah Almazyed, Khulud Saeed Alghamdi, Sarah Musaad Alrashidi, Waad Abdullah Qaeed, Amjad Aedh Alasmari
  Pharmacophore.2021; 12(3): 91.     CrossRef
• Type 2 diabetes mellitus management in patients with chronic kidney disease: an update
  Zoi Kleinaki, Stella Kapnisi, Sofia-Andriani Theodorelou-Charitou, Ilias P. Nikas, Stavroula A. Paschou
  Hormones.2020; 19(4): 467.     CrossRef
• Renal Outcomes in Type 2 Diabetes: A Review of Cardiovascular and Renal Outcome Trials
  David M. Williams, Asif Nawaz, Marc Evans
  Diabetes Therapy.2020; 11(2): 369.     CrossRef
• Favorable pleiotropic effects of sodium glucose cotransporter 2 inhibitors: head-to-head comparisons with dipeptidyl peptidase-4 inhibitors in type 2 diabetes patients
  Shih-Chieh Shao, Kai-Cheng Chang, Swu-Jane Lin, Rong-Nan Chien, Ming-Jui Hung, Yuk-Ying Chan, Yea-Huei Kao Yang, Edward Chia-Cheng Lai
  Cardiovascular Diabetology.2020;[Epub]     CrossRef
• Novel therapeutic agents for the treatment of diabetic kidney disease
  Rachel E. Hartman, P.S.S. Rao, Mariann D. Churchwell, Susan J. Lewis
  Expert Opinion on Investigational Drugs.2020; 29(11): 1277.     CrossRef
• Renal protection with glucagon-like peptide-1 receptor agonists
  Martina Vitale, Jonida Haxhi, Tiziana Cirrito, Giuseppe Pugliese
  Current Opinion in Pharmacology.2020; 54: 91.     CrossRef
• Loss of Mitochondrial Control Impacts Renal Health
  Swayam Prakash Srivastava, Keizo Kanasaki, Julie E. Goodwin
  Frontiers in Pharmacology.2020;[Epub]     CrossRef
• Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  Jae Hyun Bae, Eun-Gee Park, Sunhee Kim, Sin Gon Kim, Seokyung Hahn, Nam Hoon Kim
  Scientific Reports.2019;[Epub]     CrossRef

The rapid increase in diabetes prevalence globally has contributed to large increases in health care expenditure on diabetic complications, posing a major health burden to countries worldwide. Asians are commonly observed to have poorer β-cell function and greater insulin resistance compared to the Caucasian population, which is attributed by their lower lean body mass and central obesity. This “double phenotype” as well as the rising prevalence of young onset diabetes in Asia has placed Asians with diabetes at high risk of cardiovascular and renal complications, with cancer emerging as an important cause of morbidity and mortality. The experience from Hong Kong had demonstrated that a multifaceted approach, involving team-based integrated care, information technological advances, and patient empowerment programs were able to reduce the incidence of diabetic complications, hospitalizations, and mortality. System change and public policies to enhance implementation of such programs may provide solutions to combat the burgeoning health problem of diabetes at a societal level.

Citations

Citations to this article as recorded by  

• Spatial alteration of metabolites in diabetic cortical cataracts: New insight into lactate
  Pengfei Li, Miaomiao Wu, Rong Wang, Guowei Zhang, Lihua Kang, Huaijin Guan, Min Ji
  Experimental Eye Research.2025; 255: 110361.     CrossRef
• Impact of Body Composition and Anemia on Accuracy of a Real-Time Continuous Glucose Monitor in Diabetes Patients on Continuous Ambulatory Peritoneal Dialysis
  James Ling, Jack K.C. Ng, Eric S.H. Lau, Andrea O.Y. Luk, Ronald C.W. Ma, Robert A. Vigersky, Philip K.T. Li, Juliana C.N. Chan, Cheuk Chun Szeto, Elaine Chow
  Diabetes Technology & Therapeutics.2024; 26(1): 70.     CrossRef
• The Development of the Municipal Registry of People with Diabetes in Porto Alegre, Brazil
  Rafael Dal Moro, Lucas Helal, Leonel Almeida, Jorge Osório, Maria Ines Schmidt, Sotero Mengue, Bruce B. Duncan
  Journal of Clinical Medicine.2024; 13(10): 2783.     CrossRef
• Lipids as the link between central obesity and diabetes: perspectives from mediation analysis
  Song Lu, Maobin Kuang, Jiajun Qiu, Wenjuan Li, Min Zhang, Guotai Sheng, Yang Zou, Xiaoping Peng
  BMC Endocrine Disorders.2024;[Epub]     CrossRef
• Levels and correlates of risk factor control in diabetes mellitus –ELSA-Brasil
  Bruna Cristine Chwal, Rodrigo Citton Padilha dos Reis, Maria Inês Schmidt, Bruce B. Duncan, Sandhi Maria Barreto, Rosane Harter Griep
  Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
• Trends in risk factor control and treatment among patients with non‐alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory‐wide study
  Xinrong Zhang, Terry Cheuk‐Fung Yip, Yee‐Kit Tse, Vicki Wing‐Ki Hui, Guanlin Li, Huapeng Lin, Lilian Yan Liang, Jimmy Che‐To Lai, Mandy Sze‐Man Lai, Johnny T. K. Cheung, Henry Lik‐Yuen Chan, Stephen Lam Chan, Alice Pik‐Shan Kong, Grace Lai‐Hung Wong, Vinc
  Alimentary Pharmacology & Therapeutics.2023; 57(10): 1103.     CrossRef
• Team-Based Diabetes Care in Ontario and Hong Kong: a Comparative Review
  Calvin Ke, Emaad Mohammad, Juliana C. N. Chan, Alice P. S. Kong, Fok-Han Leung, Baiju R. Shah, Douglas Lee, Andrea O. Luk, Ronald C. W. Ma, Elaine Chow, Xiaolin Wei
  Current Diabetes Reports.2023; 23(7): 135.     CrossRef
• Team-Based Approach to Reduce Malignancies in People with Diabetes and Obesity
  Ziyue Zhu, Samuel Yeung Shan Wong, Joseph Jao Yiu Sung, Thomas Yuen Tung Lam
  Current Diabetes Reports.2023; 23(10): 253.     CrossRef
• Professor Juliana Chung Ngor Chan: Tireless Trailblazer for Diabetes Research, Care, and Education in Asia
  Ronald C.W. Ma, Wing Yee So, Andrea O.Y. Luk
  Diabetes Care.2022; 45(10): 2207.     CrossRef
• Predicting the Development of Myocardial Infarction in Middle-Aged Adults with Type 2 Diabetes: A Risk Model Generated from a Nationwide Population-Based Cohort Study in Korea
  Seung-Hwan Lee, Kyungdo Han, Hun-Sung Kim, Jae-Hyoung Cho, Kun-Ho Yoon, Mee Kyoung Kim
  Endocrinology and Metabolism.2020; 35(3): 636.     CrossRef
• From Hong Kong Diabetes Register to JADE Program to RAMP-DM for Data-Driven Actions
  Juliana C.N. Chan, Lee-Ling Lim, Andrea O.Y. Luk, Risa Ozaki, Alice P.S. Kong, Ronald C.W. Ma, Wing-Yee So, Su-Vui Lo
  Diabetes Care.2019; 42(11): 2022.     CrossRef
• Cholesterol levels and development of cardiovascular disease in Koreans with type 2 diabetes mellitus and without pre-existing cardiovascular disease
  Mee Kyoung Kim, Kyungdo Han, Han Na Joung, Ki-Hyun Baek, Ki-Ho Song, Hyuk-Sang Kwon
  Cardiovascular Diabetology.2019;[Epub]     CrossRef
• Effects of Variability in Blood Pressure, Glucose, and Cholesterol Concentrations, and Body Mass Index on End-Stage Renal Disease in the General Population of Korea
  Mee Kyoung Kim, Kyungdo Han, Hun-Sung Kim, Yong-Moon Park, Hyuk-Sang Kwon, Kun-Ho Yoon, Seung-Hwan Lee
  Journal of Clinical Medicine.2019; 8(5): 755.     CrossRef
• Efficacy and safety of fixed‐dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double‐blind, controlled, phase 3 trial
  Ji Cheol Bae, Kyung Wan Min, Yong Hyun Kim, Kyoung‐Ah Kim, Eun‐Gyoung Hong, Cheol‐Young Park, Song Han, Bong‐Soo Cha
  Diabetes, Obesity and Metabolism.2019; 21(1): 103.     CrossRef
• Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
  Yongin Cho, Myoung Soo Kim, Chung Mo Nam, Eun Seok Kang
  Scientific Reports.2019;[Epub]     CrossRef